BACKGROUND Valvular heart disease affects more than 100 million people worldwide and is associated with significant morbidity and mortality.The prevalence of at least moderate valvular heart disease is 2.5%across all ...
supported by the National Natural Science Foundation of China grant 82170970(YW),81970944(LZ),82300452(CW);Sichuan Science and Technology Program 2023NSFSC0553(LZ),2019JDRC0104(JG),2022YFS0359,2024YFFK0238(TW),2022YFS0187(DY),24QYCX0412(JZ),2024YFFK0239(JG),2024YFFK0237(CW);Post-Doctor Research Project of West China Hospital;Sichuan University2023HXBH108(JG)。
Periodontitis is a chronic inflammatory disease initiated by biofilm microorganisms and mediated by host immune imbalance.Uncontrolled periodontal infections are the leading cause of tooth loss in adults.Thrombotic di...
Supported by Chinese and Western Medicine Cooperation Project of Subei People's Hospital(No.ZXXTGG2022BO3);Jiangsu Graduate Scientific Research Innovation Program(No.SJCX22 1813)。
Objective:To investigate the inhibitory effect of Celastrus orbiculatus extracts(COE)on the proliferation of lymphoma cells and the immune regulation ability on inflammation and thrombophilia in vivo.Methods:The 38B9 ...
supported by grants from the National Natural Science Foundation of China(Nos.81900597,81970567);the Natural Science Foundation of Guangdong Province,China(Nos.2019A1515011698,2021A1515012136,2021A1515010571,2018A030313043);Science and Technology Program of Guangzhou City(No.201803040005);National Bioengineering Research Center Cultivation Platform(No.WW201905);the Major Talent Project Cultivation Plan Project(No.P02093).
To the Editor:Despite dramatic improvements in the prognosis of pediatric liver transplantation(LT),postoperative complications are still a leading cause of death in grafts and patients.Child recipients were shown to ...
supported by the National Natural Science Foundation of China(Nos.81700130,82370134,92169114,81802932);the Natural Science Fund for Distinguished Young Scholars of Hubei Province(No.2022CFA054);the National Key Research and Development Program of China(No.2018YFE0113600).
Corona virus disease 2019(COVID-19)due to severe acute respiratory syndrome coronavirus 2(SARS-CoV-2)infection has affected the whole world.Acquired thrombotic thrombocytopenic purpura(TTP)has been reported after admi...
Sichuan Province Medical Research Project Plan(Project No.S21113)。
This study explores the diagnostic value of combining the Padua score with the thrombotic biomarker tissue plasminogen activator inhibitor-1(tPAI-1)for assessing the risk of deep vein thrombosis(DVT)in patients with p...
BACKGROUND It is well-described that the coronavirus disease 2019(COVID-19)infection is associated with an increased risk of thrombotic complications.While there have been many cases of pulmonary emboli and deep vein ...
Liver transplantation(LT)is the life saving therapeutic option for patients with acute and chronic end stage liver disease.This is a routine procedure with excellent outcomes in terms of patient survival and quality o...
BACKGROUND Presently,there is no established standard anti-blood clot therapy for patients facing acute myocardial infarction(AMI)complicated by left ventricular thrombus(LVT).While vitamin K antagonists are the prefe...
supported by the National Natural Science Foundation of China(No.82003561).
Objective Thrombotic thrombocytopenic purpura(TTP)is a rare and fatal disease caused by a severe deficiency in the metalloprotease ADAMTS13 and is characterized by thrombotic microangiopathy.The present study aimed to...